XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2021
Dec. 31, 2020
Current Assets:    
Cash and cash equivalents $ 67,877 $ 1,839
Restricted cash 435 530
Accounts receivable, net 49,015 6,703
Inventories 3,455 117
Due from related parties 37 0
Prepaid expenses and other current assets 8,771 3,501
Total current assets 129,590 12,690
Property and equipment, net 55,785 151
Intangible assets, net 119,955 27,782
Goodwill 581,814 164,194
Equity method investments 0 57,214
Deferred tax assets 0 335
Other assets 1,897 24
Total assets 889,041 262,390
Current Liabilities:    
Accounts payable 10,065 2,680
Accrued expenses 34,718 8,482
Deferred revenue 5,348 397
Due to related party 56 70
Income taxes payable 916 673
Related-party long-term debt, current 670 39
Long-term debt, current 43,849 22,531
Derivative liability, current 1,633 0
Forward share purchase liability 17,577 0
Other current liabilities 1,048 0
Total current liabilities 115,880 34,872
Related-party long-term debt, noncurrent 0 381
Long-term debt, noncurrent 99,079 344
Deferred tax liabilities 31,059 6,072
Warrant liabilities, noncurrent 399 0
Derivative liability, noncurrent 10,305 0
Other long-term liabilities 3,399 0
Total liabilities 260,121 41,669
Commitments and Contingencies
Stockholders’ Equity:    
Preferred stock, $0.0001 par value, 1,000 shares authorized; none issued or outstanding 0 0
Common stock, $0.0001 par value, 300,000 shares authorized; 117,800 issued and outstanding at September 30, 2021; 70,021 issued and outstanding at December 31, 2020 12 7
Additional paid-in capital 621,861 222,900
Accumulated deficit (5,328) (2,186)
Accumulated other comprehensive loss (3,459) 0
Total UpHealth, Inc., stockholders’ equity 613,086 220,721
Noncontrolling interests 15,834 0
Total stockholders’ equity 628,920 220,721 [1]
Total liabilities and stockholders’ equity $ 889,041 $ 262,390
[1] (1) Amounts as of March 31, 2021 and before that date differ from those published in prior consolidated financial statements as they were retrospectively adjusted as a result of the accounting for the Business Combinations (as defined below in Note 1). Specifically, the number of common shares outstanding during periods before the Business Combinations are computed on the basis of the number of common shares of UpHealth Holdings (accounting acquiror) during those periods multiplied by the exchange ratio established in the stock purchase agreement (1.00 UpHealth Holdings shares converted to 10.28 GigCapital2 shares). Common stock and additional paid-in capital were adjusted accordingly.